OFM
Omega Fund Management Portfolio holdings
AUM
$154M
This Quarter Return
-16.34%
1 Year Return
-32.78%
3 Year Return
+82.35%
5 Year Return
+29.08%
10 Year Return
+90.46%
AUM
$242M
AUM Growth
+$242M
(-23%)
Cap. Flow
+$7.91M
Cap. Flow
% of AUM
3.27%
Top 10 Holdings %
Top 10 Hldgs %
92.28%
Holding
16
New
2
Increased
1
Reduced
3
Closed
–
Top Buys
1 |
Arcutis Biotherapeutics
ARQT
|
$25.2M |
2 |
Beam Therapeutics
BEAM
|
$5.45M |
3 |
Cidara Therapeutics
CDTX
|
$912K |
Top Sells
1 |
Gossamer Bio
GOSS
|
$18.7M |
2 |
PRVL
Prevail Therapeutics Inc. Common Stock
PRVL
|
$4.83M |
3 |
ESSA Pharma
EPIX
|
$80K |
Sector Composition
1 | Healthcare | 100% |